Epi-hne4 dx-890 (DrugBank: -)
1 disease| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 299 | Cystic fibrosis | 3 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2004-002341-12-BE (EUCTR) | 05/08/2005 | 25/08/2005 | Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients | Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients | Cystic fibrosis MedDRA version: 7.0;Level: PT;Classification code 10011762 | Product Name: Depelestat Product Code: EPI-hNE4 DX-890 INN or Proposed INN: Depelestat Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase INN or Proposed INN: Depelestat Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase | Debiopharm SA | NULL | Not Recruiting | Female: yes Male: yes | 90 | United Kingdom;Germany;Belgium;Italy | |||
| 2 | EUCTR2004-002341-12-GB (EUCTR) | 15/04/2005 | 10/02/2005 | Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients | Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients | Cystic fibrosis MedDRA version: 7.0;Level: PT;Classification code 10011762 | Product Name: Depelestat Product Code: EPI-hNE4 DX-890 INN or Proposed INN: Depelestat Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase INN or Proposed INN: Depelestat Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase | Debiopharm SA | NULL | Not Recruiting | Female: yes Male: yes | 90 | Phase 2 | Belgium;Germany;Italy;United Kingdom | ||
| 3 | EUCTR2004-002341-12-DE (EUCTR) | 14/02/2005 | 24/09/2004 | Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients | Multicenter, 8-week, Randomised, Double-Blind, Placebo Controlled Study of Two Doses of Depelestat in Cystic Fibrosis Patients | Cystic fibrosis MedDRA version: 7.0;Level: PT;Classification code 10011762 | Product Name: Depelestat Product Code: EPI-hNE4 DX-890 INN or Proposed INN: Depelestat Other descriptive name: Engineered Protein Inhibitor of human Neutrophil Elastase INN or Proposed INN: Depelestat Other descriptive name: Engineerd Protein Inhibitor of human Neutrophil Elastase | Debiopharm SA | NULL | Not Recruiting | Female: yes Male: yes | 90 | United Kingdom;Germany;Belgium;Italy |